|
HCM
|
Hutchison China MediTech Limited
|
0.06%
|
US
|
NASDAQ
|
|
ME
|
23andMe Holding Co.
|
0.06%
|
US
|
NASDAQ
|
|
VNDA
|
Vanda Pharmaceuticals Inc.
|
0.05%
|
US
|
NASDAQ
|
|
TBPH
|
Theravance Biopharma, Inc.
|
0.05%
|
US
|
NASDAQ
|
|
STOK
|
Stoke Therapeutics, Inc.
|
0.05%
|
US
|
NASDAQ
|
|
SGMO
|
Sangamo BioSciences, Inc.
|
0.05%
|
US
|
NASDAQ
|
|
RYTM
|
Rhythm Pharmaceuticals, Inc.
|
0.05%
|
US
|
NASDAQ
|
|
NUVL
|
Nuvalent, Inc.
|
0.05%
|
US
|
NASDAQ
|
|
NSTG
|
NanoString Technologies, Inc.
|
0.05%
|
US
|
NASDAQ
|
|
NKTX
|
Nkarta, Inc.
|
0.05%
|
US
|
NASDAQ
|
|
IPSC
|
Century Therapeutics, Inc.
|
0.05%
|
US
|
NASDAQ
|
|
INBX
|
Inhibrx, Inc.
|
0.05%
|
US
|
NASDAQ
|
|
IDYA
|
IDEAYA Biosciences, Inc.
|
0.05%
|
US
|
NASDAQ
|
|
COLL
|
Collegium Pharmaceutical, Inc.
|
0.05%
|
US
|
NASDAQ
|
|
CHRS
|
Coherus BioSciences, Inc.
|
0.05%
|
US
|
NASDAQ
|
|
CGEM
|
Cullinan Management, Inc.
|
0.05%
|
US
|
NASDAQ
|
|
BCYC
|
Bicycle Therapeutics plc
|
0.05%
|
US
|
NASDAQ
|
|
ATAI
|
ATAI Life Sciences N.V.
|
0.05%
|
US
|
NASDAQ
|
|
ANAB
|
AnaptysBio, Inc.
|
0.05%
|
US
|
NASDAQ
|
|
ACET
|
Adicet Bio, Inc.
|
0.05%
|
US
|
NASDAQ
|